[1] |
GOTO H, TANAKA A, KONDO F, et al. Carcinosarcoma of the liver[J]. Int Med, 2010, 49(23): 2577-2582. DOI: 10.2169/internalmedicine.49.3581.
|
[2] |
YAMMOTO T, KURASHIMA Y, OHATA K, et al. Carcinosarcoma of the liver: Report of a case[J]. Surg Today, 2014, 44(6): 1161-1170. DOI: 10.1007/s00595-013-0612-7.
|
[3] |
LAO XM, CHEN DY, ZHANG YQ, et al. Primary carcinosarcoma of the liver: Clinicopathologic features of 5 cases and a review of the literature[J]. Am J Surg Pathol, 2007, 31(6): 817-826. DOI: 10.1097/01.pas.0000213431.07116.e0.
|
[4] |
LIN YS, WANG TY, LIN JC, et al. Hepatic carcinosarcoma: Clinicopathologic features and a review of the literature[J]. Ann Hepatol, 2013, 12(3): 495-500. DOI: 10.1016/S1665-2681(19)31015-4.
|
[5] |
SUMIYOSHI S, KIKUYAMA M, MATSUBAYASHI Y, et al. Carcinosarcoma of the liver with mesenchymal differentiation[J]. World J Gastroenterol, 2007, 13(5): 809-812. DOI: 10.3748/wjg.v13.i5.809.
|
[6] |
LI J, LIANG P, ZHANG D, et al. Primary carcinosarcoma of the liver: Imaging features and clinical findings in six cases and a review of the literature[J]. Cancer Imaging, 2018, 18(1): 7. DOI: 10.1186/s40644-018-0141-0.
|
[7] |
OFUCHI T, IMAI K, NAKAO Y, et al. A case of primary carcinosarcoma of the liver with combined hepatocellular carcinoma and cholangiocarcinoma[J]. Clin J Gastroenterol, 2021, 14(5): 1476-1483. DOI: 10.1007/s12328-021-01469-5.
|
[8] |
CELIKBILEK M, DENIZ K, TORUN E, et al. Primary hepatic carcinosarcoma[J]. Hepatobiliary Pancreat Dis Int, 2011, 10(1): 101-103. DOI: 10.1016/S1499-3872(11)60015-5.
|
[9] |
XIANG S, CHEN Y F, GUAN Y, et al. Primary combined hepatocellular-cholangiocellular sarcoma: An unusual case[J]. World J Gastroenterol, 2015, 21(23): 7335-7342. DOI: 10.3748/wjg.v21.i23.7335.
|
[10] |
HUANG L, LU L. Case report: Review of CT findings and histopathological characteristics of primary liver carcinosarcoma[J]. Front Genet, 2021, 12: 638636. DOI: 10.3389/fgene.2021.638636.
|
[11] |
ZHAO L, YANG Y, GAO Q. Efficacy and safety of nivolumab plus apatinib in advanced liver carcinosarcoma: A case report[J]. Immunotherapy, 2019, 11(8): 651-656. DOI: 10.2217/imt-2018-0214.
|